Using a qualitative approach, two researchers uncover the many factors that contribute to an HIV-positive gay man’s decision to migrate to and remain in a certain city or country.
Innovative new optimisation-based tools aim to make European process industries more energy-efficient and cost-effective.
New research shows how QSOX1 inhibitory antibodies can slow tumour growth and metastasis, potentially opening the door to an anti-metastatic cancer drug.
New technology lets farmers see the type of microorganisms that are present in a particular soil type and tailor their resources accordingly.
A group of young researchers in the Netherlands are working to control the quantum phase transition in electronic devices.
New research advances our understanding of what causes splenic marginal zone lymphoma and chronic lymphocytic leukaemia.
New research shows how the nervous and immune systems ‘talk’ to each other to promote health and fight disease.
New theoretical models and search strategies aim to help solve the dark matter puzzle.
Despite making up nearly 80 % of the universe’s matter, dark matter remains largely a mystery. “Although there is overwhelming evidence that dark matter exists at all cosmological scales, no experiment has yet been able to identify this elusive substance,” says Kai Schmidt-Hoberg, a physicist at DESY. “As such, when it comes to understanding what dark matter consists of and how it acts, we remain largely in...
Innovative methods for cultivating algae and converting it into sustainable feedstock open the door to creating a bio-based blue economy in Europe.
The discovery of a cell type that essentially hides from conventional therapy could open the door to new ways of treating cancer.
Archaeological fieldwork in West Africa is expanding our knowledge about human evolution and helping unravel the story of our success as a species.
New research demonstrates how biohybrid and biodegradable nanovaccines can provide effective, personalised cancer treatment.